|
|
|
28 Jul 2007 |
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
|
|
27 Jul 2007 |
Exelixis Retains Right to Develop and Commercialize XL647
|
|
26 Jul 2007 |
Spectrum Pharmaceuticals Acquires From Indena Worldwide Rights To Ortataxel, A Phase 2 Third Generation Taxane
|
|
25 Jul 2007 |
Kissei Entered into an Agreement with Nuon Therapeutics, Inc on Tranilast (Product Name: Rizaben(R))
|
|
20 Jul 2007 |
Schering-Plough Announces Licensing of Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
|
|
19 Jul 2007 |
Merck Transfers Abbott Rights for Niaspan Outside the U.S.
|
|
18 Jul 2007 |
Penwest Enters Into Collaboration Agreement With Edison Pharmaceuticals
|
|
18 Jul 2007 |
Ambrilia Completes Korean Licensing Partnership with Shin Poong for its Long-Acting Formulation of Octreotide
|
|
17 Jul 2007 |
Prometic and Laboratorios Dermatologicos Darier S.A. enter into agreement for PBI-1308 with respect to dermatological disorders
|
|
17 Jul 2007 |
PreMD Signs Marketing and Distribution Agreement with AstraZeneca
|
|
13 Jul 2007 |
Amgen and Daiichi Sankyo announce agreement for denosumab in Japan
|
|
13 Jul 2007 |
ARIAD and Merck & Co., Inc. Announce Global Collaboration to Jointly Develop and Commercialize AP23573 (ARIAD's Novel mTOR Inhibitor) for Cancer
|
|
11 Jul 2007 |
Cipher pharmaceuticals enters into US licensing and distribution agreement for Lipofen
|
|
11 Jul 2007 |
Tercica Announces Agreement with Genentech for Worldwide Growth Hormone and IGF-1 Combination Product Development and Commercialization
|
|
11 Jul 2007 |
Macrochem Acquires Option To License Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infection, from Genaera
|
|
10 Jul 2007 |
Peregrine Acquires Worldwide Rights to Novel Anti-Angiogenesis Technology From M. D. Anderson Cancer Center
|
|
10 Jul 2007 |
Novavax Licenses Wyeth's Virus-Like Particle Technology
|
|
10 Jul 2007 |
Warner Chilcott and Paratek Pharmaceuticals Sign Collaboration Agreement for Novel, Narrow-Spectrum Agents for Acne and Rosacea
|
|
10 Jul 2007 |
Roche and Alnylam form major alliance on RNAi therapeutics
|
|
07 Jul 2007 |
siRNA collaboration with AstraZeneca
|
|
03 Jul 2007 |
Novartis enhances its vaccine pipeline by gaining access to Intercell's key technologies and vaccines programs
|
|
03 Jul 2007 |
Biogen Idec and cardiokine partner to develop Lixivaptan, a novel vasopressin antagonist
|
|
03 Jul 2007 |
Santhera Licenses Omigapil for Treatment of Rare Neuromuscular Diseases
|
|
28 Jun 2007 |
Ipsen announces license agreement with PregLem SA in field of reproductive medicine
|
|
28 Jun 2007 |
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
|
|
27 Jun 2007 |
Wyeth licenses drug targets from osteoporosis collaboration with Galapagos
|
|
26 Jun 2007 |
Abbott and Genentech Announce Global, Integrated Research, Development and Commercialization Collaboration in Oncology
|
|
26 Jun 2007 |
GPC Biotech Announces Partnering Agreement for Satraplatin for Japan with Yakult
|
|
26 Jun 2007 |
Roche and Toyama Chemical enter licensing agreement to develop potential breakthrough drug to treat rheumatoid arthritis
|
|
22 Jun 2007 |
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
|
|
22 Jun 2007 |
Oncolys BioPharma and Tacere Therapeutics form strategic alliance to develop RNAi Hepatitis C drug
|
|
21 Jun 2007 |
Shire in-licenses JUVISTA(R) (human TGFβ3) from Renovo
|
|
20 Jun 2007 |
Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
|
|
20 Jun 2007 |
DeveloGen and Teva Enter into Exclusive License Agreement for DeveloGen’s Protein Kinase B Technology for the Treatment of Cancer
|
|
20 Jun 2007 |
ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
|
|
13 Jun 2007 |
Favrille Acquires Anti-CD20 Monoclonal Antibodies from Diversa
|
|
13 Jun 2007 |
Kissei and Eisai sign a license agreement to develop and commercialize Glufast(R), a rapid-acting insulin secretagogue in 10 ASEAN countries
|
|
12 Jun 2007 |
Merck Signs Strategic Alliance With Archemix
|
|
12 Jun 2007 |
Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
|
|
12 Jun 2007 |
NEOPHARM, Inc. Signs Exclusive License Agreement for the Use of CINTREDEKIN BESUDOTOX (IL13-PE38QQR) for the Treatment of Pulmonary Fibrosis and Asthma
|
|
02 Jun 2007 |
Indigo Pharmaceuticals, Inc. Signs License Agreement for INDI-702, a Drug for the Treatment of Arteriosclerosis Obliterans, With Nissan Chemical Industries and Taisho Pharmaceutical Co.
|
|
01 Jun 2007 |
ProBioGen and Virbac signed a Licensing Agreement to use ProBioGen’s Novel Avian Cell Line AGE1 for Production of Biological Products
|
|
31 May 2007 |
Novacea and Schering-Plough Enter into Worldwide Development and Commercialization Agreement for Asentar, a Novel Treatment for Prostate Cancer
|
|
31 May 2007 |
BioWa and Takeda announce licensing of BioWa's POTELLIGENT(R) technology for use in antibody research and development
|
|
31 May 2007 |
CeNeRx BioPharma, Inc. Announces Agreement With PharmaNess Neuroscience to Develop Novel Cannabinoid Compounds
|
|
25 May 2007 |
Micromet and Nycomed Enter Into Exclusive Worldwide Collaboration to Develop and Commercialize Anti-GM-CSF Antibodies for the Treatment of Inflammatory and Autoimmune Diseases
|
|
23 May 2007 |
New Agreement Boosts Pipeline for Synosia Therapeutics
|
|
17 May 2007 |
CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of Becocalcidiol
|
|
11 May 2007 |
Viropro Inc. and Intas Biopharmaceuticals Announce the Signature of a Binding MOU for the Development and Production of a Therapeutic Protein
|
|
07 May 2007 |
Affitech Signs Antibody Research and Licensing Agreement with Roche
|
| |
|
Results 301 - 350 of 814 |
